Form 4 Filing for BIO-TECHNE Corp

John L. Higgins, a director at BIO-TECHNE Corp (TECH), reported a series of transactions on September 28, 2026. Higgins acquired 15,940 shares of Common Stock in a non-derivative transaction coded "M" with a transaction price of $0.00, increasing his post-transaction holdings to 82,816 shares. He also disposed of 5,562 shares of Common Stock in a non-derivative transaction coded "F", with a price per share of $72.51, resulting in 77,254 shares remaining. Additionally, Higgins disposed of 15,940 stock options (right to buy) in a derivative transaction coded "M" with a transaction price of $0.00. These options were linked to 15,940 shares of Common Stock. The filing also details various derivative holdings, primarily stock options, with different exercise prices and expiration dates, some of which are subject to vesting conditions tied to the company's annual meeting.